Agent |
Process/Definitions |
Action |
| Embryonic
cells from species that have 9 months gestation period. |
Defined
as cells in the first trimester of development. |
First
trimester cells are observed to be "process specific," whereas later
developed fetal cells become increasingly "organism specific" through
biological differentiation. |
| Embryonic
organ cells (e.g., spinal and brainstem). |
Organ
cells which are chosen to correspond with injured host organ. |
Cells
gradually assume morphology and growth processes of the host rather
than the donar organism at the appropriate organ site. |
| Injected
embryonic organ cells. |
Enter
blood stream of host organism and migrate to appropriate organ site. |
The
cellular material is brought to the organ site through macrophage
(white cells). |
| Embryonic
cells at organ site (e.g., spinal cord injury). |
Cells
assume normal growth process of the host organism. |
Neural
fibers sprout and gradually develop at injury site. |
| New
neural fibers. |
Develop
new neural matrix that forms bridge across injury site. |
Fibers
begin first to receive and transmit sensory data, which requires
less specific pathway differentiation than motor pathways. |
| New
neural matrix. |
The
growing neural matrix is provided with specific pathway excitation
through muscular movements generated systematically during physical
rehabilitation regimen. |
Excitation
patterns stimulate growth and reinforce specific neuro-sensory and
motor pathways. |
| Neural
growth factors. |
Agents
that stimulate neural growth, including myelination.
First observed by Dr. Marshall Gosh of
Rochester, NY (M. Gosh, et al, Progress in Brain Research,
60, 1983, p. 189).
|
Stimulates
new communication among cells and contributes to growth of neural
fibers.
Current research reconfirms this action.
(See research reviews available upon request).
|
4AP
(4-Aminopyridine) |
Used
to improve nerve conduction in myelin- damaged neural fibers.
Known efficacy in MS and spinal cord injuries.
|
Potassium
channel blocker; prolongs duration of nerve action potentials; improves
conduction in demyelinated axons. |
| Cyst
Retinoic Acid |
A
form of Vitamin D. |
Acts
to grow neural fibers in correct spatial orientation for proper
conduction. |
| Creatine |
Used
to enhance physical therapy. |
Stimulates
muscle strength. |
| Physical
Rehabilitation Therapy |
Strengthens
striated muscle groups. |
Retrains
neural pathways used in motor activities. |